Showing results (11-20 of 229) with videos related to
Sort By:
Pageof 23
Current Opinion in Hematology|May 27, 2009
Impact of new prognostic markers in treatment decisions in acute myeloid leukemiaRichard F Schlenk, Konstanze DöhnerCurrent Oncology Reports|July 17, 2021
Post-Induction Treatment for Acute Myeloid Leukemia: Something Change?Sonia Jaramillo, Richard F SchlenkJournal of Bacteriology|October 1, 1974
Active transport of exogenous S-adenosylmethionine and related compounds into cells and vacuoles of Saccharomyces cerevisiaeK D Nakamura, F SchlenkExpert Opinion on Biological Therapy|August 4, 2011
Gemtuzumab ozogamicin in non-acute promyelocytic acute myeloid leukemiaMarie-Luise Hütter, Richard F SchlenkDer Internist|January 30, 2013
[Acute myeloid leukemia. Genetic diagnostics and molecular therapy]R F Schlenk, K Döhner, H DöhnerDer Internist|November 11, 2011
[Current treatment options in acute myeloid leukemia]M Heuser, R F Schlenk, A GanserLeukemia|May 11, 2018
Management of patients with acute promyelocytic leukemiaSabine Kayser, Richard F Schlenk, Uwe PlatzbeckerExpert Review of Clinical Pharmacology|September 30, 2017
Midostaurin treatment in FLT3-mutated acute myeloid leukemia and systemic mastocytosisSabine Kayser, Mark J Levis, Richard F SchlenkSeminars in Hematology|March 31, 2019
What's new in consolidation therapy in AML?Richard F Schlenk, Sonia Jaramillo, Carsten Müller-TidowDeutsche Medizinische Wochenschrift (1946)|October 12, 2012
[Novel therapeutic options in the treatment of BCR/ABL-negative myeloproliferative neoplasms]K Döhner, F Stegelmann, R F Schlenk, et al.Pageof 23